<DOC>
	<DOCNO>NCT01198808</DOCNO>
	<brief_summary>Bladder cancer generally susceptible immunotherapeutic measure . The investigator characterize 40 patient muscle-invasive bladder cancer regard existence frequency tumorspecific T-cells regulatory T cell . The find data correlate clinical data cancer-specific survival response chemotherapy . It hypothesize patient high number Tregs tumor-specific T-cells worse prognosis .</brief_summary>
	<brief_title>Tumorspecific T-cell Immunity Bladder Cancer Prognostic Marker</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Histologically confirm muscleinvasive urothelial carcinoma Age &gt; 18 year Hemoglobin &gt; 10g/dl Signed Informed Consent Karnofsky index &lt; 70 % Clinically relevant second malignancy Severe comorbidities ( e.g . NYHA III , endstage renal disease ) Chronic infectious disease ( HIV , Tuberculosis ) Immunosupression Severe psychiatric disease Blood donation last 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bladder cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>T cell</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Tumor-specific immunity bladder cancer</keyword>
</DOC>